Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412559![]() (US10399972, Example 50) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412560![]() ((3,9-difluoro-8-(1H-pyrazol-5- yl)-5,11-dihydro-6H...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412531![]() ((3,9-difluoro-8- ((3R,3aR,6R,6aR)-hexahydro- 3,6-e...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412530![]() ((3,9-difluoro-8-(6-oxa-2- azaspiro[3.5]nonan-2-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412563![]() ((S)-(8-(1,4-Dioxan-2-yl)-3-fluoro-5,11-dihydro-6H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 5.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412533![]() (US10399972, Example 24 | {3,9-difluoro-8-[(1S,4S)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 5.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412561![]() (US10399972, Example 52) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412528![]() ((8-((1S,4S)-2-oxa-5- azabicyclo[2.2.1]heptan-5-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412519![]() ((3-fluoro-8-((1R,3r,5S)-3- methoxy-8- azabicyclo[3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412564![]() ((R)-(8-(1,4-dioxan-2-yl)-3-fluoro-5,11-dihydro-6H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 6.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412529![]() ((8-((1S,4S)-2-oxa-5- azabicyclo[2.2.1]heptan-5-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412562![]() ((9-fluoro-8-(1-methyl-1H- pyrazol-5-yl)-5,11-dihyd...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412534![]() (US10399972, Example 25 | [3,9-difluoro-8-(6-oxa-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 7.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412527![]() ((8-((1S,4S)-2-oxa-5- azabicyclo[2.2.1]heptan-5-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 8.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412538![]() ((8-(2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-3,9- dif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 9.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412557![]() ((8-((1R,4R)-2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412538![]() ((8-(2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-3,9- dif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412548![]() (US10399972, Example 39) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 10.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412514![]() (US10399972, Example 5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 11.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412553![]() ((8-(2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-3,9- dif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 11.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412558![]() ((8-((1S,4S)-2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412515![]() (US10399972, Example 6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 12.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412566![]() ((S)-(8-(1,4-dioxan-2-yl)-9-fluoro-5,11-dihydro-6H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 12.2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412551![]() ((8-(((3-(chloromethyl)tetrahydro- 2H-pyran-3-yl)me...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 13.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412535![]() (US10399972, Example 26 | [3,9-difluoro-8-(3-oxa-8-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 13.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412539![]() ((3,9-difluoro-8-((1R,3r,5S)-3- methoxy-8- azabicyc...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 14.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412556![]() ((3,9-difluoro-8-((1R,3S,5S)-3- methoxy-8- azabicyc...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412555![]() ((8-((1S,4S)-2-oxa-5- azabicyclo[2.2.1]heptan-5-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 17.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412540![]() ((8-((1R,4R)-2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412565![]() ((R)-(8-(1,4-Dioxan-2-yl)-9-fluoro-5,11-dihydro-6H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 18.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412541![]() ((8-((1S,4S)-2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 18.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412554![]() (US10399972, Example 45) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 18.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412567![]() ((Trans-4-isopropoxycyclohexyl) 9-methyl-8-[(1S,4S)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 18.3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412516![]() ((3-fluoro-8-((3R,3aR,6R,6aR)- hexahydro-3,6-epimin...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 18.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412550![]() ((8-((1R,5S)-3,9-dioxa-7- azabicyclo[3.3.1]nonan-7-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412517![]() ((8-(2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-3- fluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 21.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412542![]() ((8-((S)-1,4-Dioxan-2-yl)-3-fluoro-5,11-dihydro-6H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 21.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412521![]() ((3-fluoro-8-(6-oxa-2- azaspiro[3.5]nonan-2-yl)-5,1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 22.1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412532![]() ((8-((2S,5S)-2,5- dimethylmorpholino)-3,9- difluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412543![]() ((8-((R)-1,4-dioxan-2-yl)-3-fluoro-5,11-dihydro-6H-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 23.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412545![]() (US10399972, Example 36) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 23.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412520![]() ((8-((2S,5S)-2,5- dimethylmorpholino)-3-fluoro- 5,1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 23.8 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412525![]() (US10399972, Example 16 | [3-fluoro-8-(6-oxa-2- aza...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412517![]() ((8-(2-oxa-5- azabicyclo[2.2.2]octan-5-yl)-3- fluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 25.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412549![]() ((3-fluoro-8-(6-oxa-2- azaspiro[3.5]nonan-2-yl)-5,1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 25.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412569![]() ((trans-4-isopropoxycyclohexyl){9- methyl-8-[(1R,4R...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 25.9 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412536![]() ((8-((1S,4S)-2-oxa-5- azabicyclo[2.2.1]heptan-5-yl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 27.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412537![]() ((9-fluoro-8-((3R,3aR,6R,6aR)- hexahydro-3,6-epimin...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 27.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412544![]() (US10399972, Example 35) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Isocitrate dehydrogenase [NADP] cytoplasmic [R132H] (Homo sapiens (Human)) | BDBM412526![]() ((3-fluoro-8-((3R,3aR,6R,6aR)- hexahydro-3,6-epimin...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | US Patent | n/a | n/a | 28.4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp... | US Patent US10399972 (2019) BindingDB Entry DOI: 10.7270/Q2TH8Q2V | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 70 total ) | Next | Last >> |